Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

about

MR Imaging Analysis of Non-Measurable Enhancing Lesions Newly Appearing after Concomitant Chemoradiotherapy in Glioblastoma Patients for Prognosis Prediction Progressive disease in glioblastoma: Benefits and limitations of semi-automated volumetry.

P2860

Q36189862-15210B80-C9DD-4B17-B6C5-5FA349F87BD7 Q36292996-0521D9D1-06A9-461C-B6DD-B4BBDA31A5E9

P2860

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

Item

http://www.wikidata.org/entity/Q48906044

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Small increases in enhancement ...... in patients with glioblastoma.

@en

Small increases in enhancement ...... in patients with glioblastoma.

@nl

type

Item

label

Small increases in enhancement ...... in patients with glioblastoma.

@en

Small increases in enhancement ...... in patients with glioblastoma.

@nl

prefLabel

Small increases in enhancement ...... in patients with glioblastoma.

@en

Small increases in enhancement ...... in patients with glioblastoma.

@nl

P1476

Small increases in enhancement ...... in patients with glioblastoma.

@en

P2093

Cecelia Elizabeth Gzell

http://www.w3.org/2001/XMLSchema#string

Helen R Wheeler

http://www.w3.org/2001/XMLSchema#string

Marina Kastelan

http://www.w3.org/2001/XMLSchema#string

Michael Back

http://www.w3.org/2001/XMLSchema#string

Philip McCloud

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Establishing percent resection and residual volume thresholds affecting survival and recurrence for patients with newly diagnosed intracranial glioblastoma.

Differentiation of true progression from pseudoprogression in glioblastoma treated with radiation therapy and concomitant temozolomide: comparison study of standard and high-b-value diffusion-weighted imaging.

Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival.

Volumetric and MGMT parameters in glioblastoma patients: survival analysis.

True progression versus pseudoprogression in the treatment of glioblastomas: a comparison study of normalized cerebral blood volume and apparent diffusion coefficient by histogram analysis

Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.

Pseudoprogression after glioma therapy: a comprehensive review.

P2888

s11060-016-2074-4

P304

67-74

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11060-016-2074-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

128

http://www.w3.org/2001/XMLSchema#string

P577

2016-02-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26879084

http://www.w3.org/2001/XMLSchema#string

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

about

P2860

P2860

Small increases in enhancement on MRI may predict survival post radiotherapy in patients with glioblastoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698